{'fraction_non_alphanumeric': 0.026297085998578537, 'fraction_numerical': 0.007107320540156361, 'mean_word_length': 5.488479262672811, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
New- and Next-Generation of Telemedicine Projects and Studies in Chronic Heart Failure, with the Example of TIM-HF2 and E-Care

Since the beginning of the 2000’s, several telemedicine projects and studies that focused on chronic heart failure have been developed with various
clinical results. Numerous new and next-generation telemedicine projects have emerged in Europe over the last five years or are still under
development as for computer science heart failure, especially in Europe. TIM-HF2 is the first positive prospective randomized study in regards of
evidence-based medicine with positive significant clinical benefit, in terms of unplanned cardiovascular hospital admissions and all-cause deaths.
The E-care telemonitoring project fits within the telemedicine 2.0 framework, based on connected objects, new Information and Communication
Technologies (ICT) and Web 2.0 technologies. E-care is the first telemedicine project including Artificial Intelligence (AI). In this setting, the
potential contribution of new- and next-generation telemedicine projects in terms of mortality, morbidity, and number of hospitalizations avoided
is currently under study. Their impact in terms of health economics is likewise being investigated, taking into account that the economic and social
benefits brought up by telemedicine solutions had previously been validated by the first-born telemedicine projects.